MedPath

Comparison of Buprenorphine and Methadone - 3

Phase 2
Completed
Conditions
Opioid-Related Disorders
Registration Number
NCT00000334
Lead Sponsor
National Institute on Drug Abuse (NIDA)
Brief Summary

The purpose of this study is to compare agonist and antagonist profile associated with buprenorphine vs. methadone during opiate withdrawal.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
Not specified
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Withdrawal severity
Opiate agonist symptoms
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Washington DC VA

🇺🇸

Washington, District of Columbia, United States

© Copyright 2025. All Rights Reserved by MedPath